Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03310619
Title A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies (PLATFORM)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Celgene
Indications

B-cell lymphoma

mediastinal malignant lymphoma

Therapies

Durvalumab + Lisocabtagene maraleucel

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center Recruiting Duarte California 91010 United States Details
H. Lee Moffitt Cancer Center and Research Institute University of South Florida Not yet recruiting Tampa Florida 33612 United States Details
Northside Hospital, Inc Recruiting Atlanta Georgia 30342 United States Details
Northwestern University School of Medicine Recruiting Chicago Illinois 60611-5975 United States Details
Massachusetts General Hospital Recruiting Boston Massachusetts 02114 United States Details
Massachusetts General Hospital Recruiting Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center Recruiting Boston Massachusetts 02215 United States Details
University of Nebraska Medical Center Recruiting Omaha Nebraska 68198-7680 United States Details
University of Pennsylvania Recruiting Philadelphia Pennsylvania 19104 United States Details
Hillman Cancer Institute at UPMC Recruiting Pittsburgh Pennsylvania 15232 United States Details
The University of Texas MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field